Recipharm AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.06.15	Recipharm Acquires OnTarget Chemistry and Extends Its Offering into Preclinical Development Services (Businesswire)
01.06.15	Recipharm AB: Recipharm appoints Chief Strategy Officer (Businesswire)
07.05.15	Recipharm AB: Interim Report January-March 2015 (Businesswire)
04.05.15	Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the First Quarter on 7 May 2015 (Businesswire)
16.04.15	Recipharm AB: Recipharm Publishes Annual Report 2014 (Businesswire)
14.04.15	Recipharm Makes Strategic Investment in Synthonics and Partners in Development of Novel Compounds (Businesswire)
08.04.15	Notice to Attend the Annual General Meeting of Recipharm AB (Publ) (Businesswire)
08.04.15	Recipharm AB: Announcement from the nomination committee concerning the Annual General Meeting 2015 (Businesswire)
27.02.15	Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
19.02.15	Recipharm AB: Full-Year-report January-December 2014 (Businesswire)
16.02.15	Recipharm AB: Invitation to Presentation of Recipharm’s Full-Year-Report for 2014 on 19 February 2015 (Businesswire)
30.01.15	Change in the Total Number of Shares and Votes in Recipharm AB (Publ) (Businesswire)
22.01.15	Recipharm Releases the Lock-up on 815,000 B-Shares Related to Shares to Be Issued upon Conversion of Convertible Bonds (Businesswire)
21.01.15	Recipharm Releases the Lock-up on 1.3 Million B-Shares Related to Shares to Be Issued upon Conversion of Convertible Bonds (Businesswire)
22.12.14	Recipharm AB: Announcement of Prospectus Regarding the Admission to Trading of New Shares in Recipharm Issued in Connection with the Acquisition of Lusomedicamenta (Businesswire)
04.12.14	Recipharm AB: Customer to Transfer Swedish Penicillin Manufacturing (Businesswire)
01.12.14	Recipharm AB: Recipharm Completes Acquisition of Flamel Technologies Facility in France (Businesswire)
28.11.14	Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
27.11.14	Recipharm AB: Recipharm Acquires Flamel Technologies Facility and Extend Development Services in France (Businesswire)
14.11.14	Recipharm AB: Invitation to Telephone Conference Due to Recipharm’s Acquisition of Lusomedicamenta (Businesswire)
13.11.14	Recipharm AB: Recipharm Acquires Lusomedicamenta for SEK 1 Billion (Businesswire)
07.11.14	Recipharm AB: Interim Report January-September 2014 (Businesswire)
05.11.14	Recipharm AB: Invitation to presentation of Recipharm’s interim report for the third quarter of 2014 on 7 November (Businesswire)
17.10.14	Recipharm AB: The Main Shareholders Implement a Division of Their Shareholdings in Recipharm (Businesswire)
01.10.14	Recipharm completes acquisition of Corvette Pharmaceutical Services Group for SEK1.1 billion (Businesswire)
19.09.14	Recipharm Secures Financing for Continued Growth (Businesswire)
11.09.14	Resolutions adopted at Extraordinary General Meeting of shareholders of Recipharm AB (publ) (Businesswire)
26.08.14	Recipharm AB: Recipharm Forms New Collaboration with Isofol Medical to Exclusively Manufacture Modufolin® and Invests SEK 8 Million in the Company (Businesswire)
20.08.14	Recipharm to Acquire Corvette Pharmaceutical Services Group for SEK 1.1 Billion (Businesswire)
19.08.14	Invitation to Extraordinary General Meeting of shareholders of Recipharm AB (publ) (Businesswire)
14.08.14	Recipharm AB: Interim report January-June 2014 (Businesswire)
11.08.14	Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the Second Quarter of 2014 on August 14Th (Businesswire)
06.05.14	Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the First Quarter of 2014 on May 8 (Businesswire)
30.04.14	Change in the Total Number of Shares and Votes in Recipharm AB (publ) ("Recipharm") (Businesswire)
11.04.14	Recipharm AB: Exercise of the over-allotment option in relation to shares of series B in Recipharm (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	85.10	3.35 %	K V
Novartis	98.15	1.54 %	K V
Roche Hldg G	298.40	1.05 %	K V
Givaudan	3’927.00	1.00 %	K V
Sika	237.80	0.85 %	K V
CieFinRichemont	180.35	0.14 %	K V
Swiss Re	138.30	-0.04 %	K V
Lonza Grp	583.60	-0.10 %	K V
ABB	52.26	-0.19 %	K V
Holcim	94.36	-0.49 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Recipharm AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten